AKNE-MYCIN- erythromycin ointment 
CORIA LABORATORIES

----------

Akne-mycin®
(Erythromycin)

2% TOPICAL OINTMENT
FOR ACNE

FOR EXTERNAL USE ONLY

Rx ONLY

DESCRIPTION

Akne-mycin (erythromycin) topical ointment contains erythromycin which is produced from a strain of Streptomyces erythraeus. Each gram of Akne-mycin topical ointment contains 20 mg of erythromycin base in a vehicle consisting of mineral oil, petrolatum, paraffin, talc, titanium dioxide, trilaureth 4 phosphate, oleyl oleate, tricetareth 4 phosphate, cetostearyl alcohol and sorbitol. Akne-mycin marketed in the United States is not of the same composition as Akne-mycin marketed in Europe.

CLINICAL PHARMACOLOGY

Although the mechanism by which Akne-mycin acts in reducing the inflammatory lesions of acne vulgaris is unknown, it is presumably due to the antibiotic action of the drug.

INDICATIONS AND USAGE

Akne-mycin is indicated for topical control of acne vulgaris.

CONTRAINDICATIONS

Akne-mycin is contraindicated in persons who have shown hypersensitivity to erythromycin or to any of the other listed ingredients.

WARNINGS

The safe use of Akne-mycin during pregnancy or lactation has not been established.

PRECAUTIONS

Akne-mycin is for topical use only and should be kept out of the eyes, nose and mouth.

The use of antibiotic agents may be associated with the overgrowth of antibiotic resistant organisms. If this occurs, administration of the drug should be discontinued and appropriate measures taken.

ADVERSE REACTIONS

In clinical trials there was one report of a possible contact sensitization which could not be confirmed. There were isolated reports of skin irritation, such as erythema and peeling.

DOSAGE AND ADMINISTRATION

Akne-mycin should be applied to the affected area twice daily, morning and evening.

HOW SUPPLIED

Akne-mycin is supplied in a 25 gram sealed tube. Store below 27°C (80°F).

Distributed by:

CORIA LABORATORIES,
a division of Valeant
Pharmaceuticals North America
Fort Worth, TX 76107
1-800-321-4576
www.CoriaLabs.com

Manufactured by:
DPT Laboratories Ltd.
San Antonio, TX 78215
129177-0610

PRINCIPAL DISPLAY PANEL - 25 g Tube Carton

Akne-mycin®2%
(Erythromycin)

NDC 13548-030-25

Rx ONLY

FOR EXTERNAL USE ONLY

TOPICAL OINTMENT
FOR ACNE

NET WT 25 g

CORIA®
LABORATORIES, LTD.

PRINCIPAL DISPLAY PANEL - 25 g Tube Carton
AKNE-MYCIN 
erythromycin ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:13548-030
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
erythromycin (erythromycin) erythromycin20 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
mineral oil 
petrolatum 
paraffin 
talc 
titanium dioxide 
oleyl oleate 
cetostearyl alcohol 
sorbitol 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13548-030-2525 g in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA05058401/10/1985
Labeler - CORIA LABORATORIES (010977972)
Registrant - Valeant Pharmaceuticals North America (831922468)
Establishment
NameAddressID/FEIBusiness Operations
DPT Laboratories Ltd.832224526MANUFACTURE

Revised: 6/2010
 
CORIA LABORATORIES